Sorrento Therapeutics Inc
(SRNE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2022 | 12-2021 | 09-2021 | 06-2021 | 03-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 111,906 | 36,665 | 39,735 | 77,291 | 41,678 |
| Marketable Securities | 158,751 | 90,217 | 122,934 | 34,410 | 194,431 |
| Receivables | 24,674 | 18,715 | 16,454 | 22,437 | 16,309 |
| Inventories | 14,086 | 8,106 | 5,427 | 2,684 | 1,779 |
| Other current assets | 8,140 | 7,482 | 3,974 | 6,784 | 3,848 |
| TOTAL | $331,115 | $172,989 | $200,720 | $155,262 | $265,701 |
| Non-Current Assets | |||||
| PPE Net | 41,705 | 41,325 | 45,750 | 45,991 | 34,681 |
| Investments And Advances | 50,667 | 51,271 | 51,120 | 162,956 | 155,979 |
| Intangibles | 338,196 | 339,230 | 373,862 | 374,897 | 116,194 |
| Other Non-Current Assets | 93,953 | 90,003 | 81,338 | 39,818 | 41,060 |
| TOTAL | $524,521 | $521,829 | $552,070 | $623,662 | $347,914 |
| Total Assets | $855,636 | $694,818 | $752,790 | $778,924 | $613,615 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 56,942 | 31,980 | 27,486 | 29,845 | 21,718 |
| Accounts payable and accrued liabilities | 32,555 | 34,951 | 93,521 | 99,651 | 25,458 |
| Accrued Expenses | 73,540 | 59,478 | 40,249 | 44,379 | 44,014 |
| Other current liabilities | 28,068 | 397 | N/A | N/A | N/A |
| TOTAL | $204,229 | $139,453 | $175,184 | $180,452 | $96,044 |
| Non-Current Liabilities | |||||
| Long Term Debt | 96,085 | 110,627 | 83,495 | 82,574 | 79,956 |
| Deferred Revenues | 673 | 1,108 | 2,284 | 2,641 | 1,120 |
| Other Non-Current Liabilities | 207,670 | 245,686 | 238,687 | 205,236 | 83,195 |
| TOTAL | $425,209 | $477,236 | $446,279 | $412,937 | $286,684 |
| Total Liabilities | $629,438 | $616,689 | $621,463 | $593,389 | $382,728 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 388,947 | 342,335 | 306,336 | 298,100 | 286,651 |
| Common Shares | 38 | 32 | 31 | 30 | 29 |
| Retained earnings | -1,427,419 | -1,386,604 | -1,242,187 | -1,122,384 | -955,769 |
| Other shareholders' equity | -1,031 | -57 | 517 | 36 | -568 |
| TOTAL | $226,198 | $78,129 | $131,327 | $185,535 | $230,887 |
| Total Liabilities And Equity | $855,636 | $694,818 | $752,790 | $778,924 | $613,615 |